AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trazumab 440mg Solution for Infusion

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Trastuzumab (440mg)

Overview Trazumab 440mg Solution for Infusion

Herceptin (trastuzumab) 440mg intravenous solution treats breast and gastric cancers by targeting and destroying HER2-positive cancer cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be immediately apparent (requiring weeks or months), discontinue only under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can lower blood cell counts, increasing infection vulnerability, necessitating regular blood tests to monitor blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment to prevent conception.

Primary Ingredients of Trazumab 440mg Solution for Infusion

No information provided. Please provide the text you wish me to rephrase.

Uses of Trazumab 440mg Solution for Infusion

Cancers affecting the breast and stomach.

Major Benefits of Trazumab 440mg Solution for Infusion:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Trazumab 440mg Solution for Infusion:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Trazumab 440mg Solution for Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Trazumab 440mg Solution for Infusion works:

The injectable formulation, Trastuzumab 440mg, is a genetically engineered monoclonal antibody (IgG1 isotype). Its mechanism targets HER2, the human epidermal growth factor receptor 2, known to drive excessive growth in breast and gastric cancers. By binding to HER2, it neutralizes the receptor's function and disrupts several associated oncogenic signaling cascades, leading to cancer cell death.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Administering Trastuzumab 440mg infusion solution concurrently with alcohol may induce pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering 440mg Trazumab infusion solution during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Patient consultation with their doctor is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Trazumab 440mg solution for infusion while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Trastuzumab 440mg Infusion Solution on driving ability is undetermined. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Trastuzumab 440mg solution for infusion in individuals with renal impairment is likely safe. Preliminary findings indicate dose modification may not be necessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Trastuzumab 440mg intravenous solution in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Trazumab 440mg Solution for Infusion :

Should you forget a scheduled Trazumab 440mg infusion, seek your physician's advice.

Facts to Know About Trazumab 440mg Solution for Infusion

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Actions Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Trazumab 440mg Solution for Infusion

Trastuzumab 440mg infusion may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, appetite loss, rapid heartbeat, urine discoloration, decreased or painful urination, and difficulty urinating. Infections may also occur. Contact your doctor immediately if you experience any of these symptoms.
Women of childbearing age must use effective contraception during and for seven months after completing Trastuzumab 440mg infusion therapy. Pregnancy planning may resume seven months post-treatment.
Treatment with Trastuzumab 440mg Solution for Infusion should continue for one year in patients with early-stage breast cancer, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Trastuzumab 440mg infusion does not require fasting. Administration must be supervised by a physician experienced in cancer chemotherapy and performed only by a qualified healthcare professional.
Traztumab 440mg Solution for Infusion is available in two formulations: intravenous (IV) and subcutaneous (SC). Always verify the label to ensure administration matches the prescription. The IV formulation is for intravenous use only and should not be administered subcutaneously. Your doctor may change your treatment between IV and SC Traztumab 440mg Solution for Infusion as needed.
Trastuzumab 440mg Solution for Infusion, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Its mechanism of action involves binding to HER2, thus inhibiting cancer cell growth and spread. Consequently, this medication is only effective in patients with HER2-positive cancer and is not indicated for those with HER2-negative disease.
Using Trastuzumab 440mg infusion with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin upon treatment initiation, continue every three months during treatment, and then every six months post-treatment for up to 24 months following the final Trastuzumab 440mg infusion. Patients with pre-existing cardiac conditions require evaluation every 12 weeks.
Trazumab 440mg Solution f...
49,590
MRP 54,663
9% off